Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Janux Therapeutics (JANX) Long-Term Debt Issuances (2020 - 2021)

Janux Therapeutics (JANX) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $69.1 million as the latest value for Q3 2021.

  • Quarterly Long-Term Debt Issuances rose 1446.97% to $69.1 million in Q3 2021 from the year-ago period, while the trailing twelve-month figure was $69.1 million through Jun 2022, up 24.01% year-over-year, with the annual reading at $124.8 million for FY2021, N/A changed from the prior year.
  • Long-Term Debt Issuances for Q3 2021 was $69.1 million at Janux Therapeutics, up from -$278000.0 in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $69.1 million in Q3 2021, with the low at -$4.5 million in Q4 2020.